Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COVID-19 breakthrough infections and humoral immune response among BNT162b2 vaccinated healthcare workers in Malaysia.
Yang SL, Mat Ripen A, Leong CT, Lee JV, Yen CH, Chand AK, Koh K, Abdul Rahim NAB, Gokilavanan V, Mohamed NNEB, Sevalingam RKA, Sulaiman N, Ab Razak AKB, Mohd Nor NHB, Pong MK, Tai KY, Toh V, Woon YL, Peariasamy KM. Yang SL, et al. Among authors: leong ct. Emerg Microbes Infect. 2022 Dec;11(1):1262-1271. doi: 10.1080/22221751.2022.2065936. Emerg Microbes Infect. 2022. PMID: 35412409 Free PMC article.
When do persuasive messages on vaccine safety steer COVID-19 vaccine acceptance and recommendations? Behavioural insights from a randomised controlled experiment in Malaysia.
Hing NYL, Woon YL, Lee YK, Kim HJ, Lothfi NM, Wong E, Perialathan K, Ahmad Sanusi NH, Isa A, Leong CT, Costa-Font J. Hing NYL, et al. Among authors: leong ct. BMJ Glob Health. 2022 Jul;7(7):e009250. doi: 10.1136/bmjgh-2022-009250. BMJ Glob Health. 2022. PMID: 35906015 Free PMC article. Clinical Trial.
Efficacy of Early Treatment With Favipiravir on Disease Progression Among High-Risk Patients With Coronavirus Disease 2019 (COVID-19): A Randomized, Open-Label Clinical Trial.
Chuah CH, Chow TS, Hor CP, Cheng JT, Ker HB, Lee HG, Lee KS, Nordin N, Ng TK, Zaid M, Zaidan NZ, Abdul Wahab S, Adnan NA, Nordin N, Tee TY, Ong SM, Chidambaram SK, Mustafa M; Malaysian Favipiravir Study Group. Chuah CH, et al. Clin Infect Dis. 2022 Aug 24;75(1):e432-e439. doi: 10.1093/cid/ciab962. Clin Infect Dis. 2022. PMID: 34849615 Clinical Trial.
Protocol for a randomised, open-label, parallel group, multicentre controlled study to evaluate the clinical performance and safety of Stay Safe Link compared with Stay Safe in patients with end-stage kidney disease on continuous ambulatory peritoneal dialysis.
Mak WY, Ong LM, Goh BL, Bavanandan S, Mushahar L, Leong CT, Hooi LS. Mak WY, et al. Among authors: leong ct. BMJ Open. 2019 Mar 8;9(3):e024589. doi: 10.1136/bmjopen-2018-024589. BMJ Open. 2019. PMID: 30852538 Free PMC article.
Clinical effectiveness of a Malaysian-manufactured CAPD product: A randomised trial.
Mak WY, Leong CT, Ong LM, Bavanandan S, Mushahar L, Goh BL, Wong HS, Ahmad G, Liew YF, Ching CH, Liu WJ, Rahmat K, Tan CH, Ahmad MK, Hassan WHHW, Chan FS, Harun Z, Loh CL, Teng KS, Tye YL, Khan SSF, Koh KH, Abdullah R, Hooi LS. Mak WY, et al. Among authors: leong ct. Perit Dial Int. 2021 May;41(3):273-283. doi: 10.1177/0896860821993954. Epub 2021 Mar 18. Perit Dial Int. 2021. PMID: 33733911 Clinical Trial.
20 results